SCHEMBL45688

SCHEMBL45688

OCC(O)C(O)P

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10535406 0.96
Ammonia Solution, Strong SCHEMBL10532387 0.96
Sulfuric Acid SCHEMBL8710062 0.85 LMNA (0.38)
SCHEMBL768133 0.79
SCHEMBL28262402 0.74 TDP1 (0.71)
E968 SCHEMBL121807 0.74
E968 SCHEMBL6729753 0.74
E968 SCHEMBL17062 0.74
E968 SCHEMBL2723809 0.74 LMNA (0.67)
E968 SCHEMBL10427336 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10633 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4398882-A1 LIPID-BASED RNA FORMULATIONS SUITABLE FOR THERAPY BioNTech SE (DE) 2024-07-17 EP claimed
US-20240226132-A1 RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2024-07-11 US claimed
WO-2024031176-A9 STABLE INJECTABLE CANNABIDIOL FORMULATIONS CARDIOL THERAPEUTICS INC. (CA) 2024-06-20 WO claimed
CN-118141783-A Biological agent for treating cataract and preparation method and application thereof 深圳市人民医院 2024-06-07 CN claimed
US-11992553-B2 Inhalable powder formulations of alginate oligomers ALGIPHARMA AS (NO) 2024-05-28 US claimed
US-20240156808-A1 Compositions and methods to improve the therapeutic benefit of suboptimally chemical compounds and biological therapies including substituted camptothecins such as irinotecan and topotecan for the treatment of benign and neoplastic hyperproliferative disease conditions, infections, inflammatory and immunological diseases EDISON ONCOLOGY (US) 2024-05-16 US claimed
EP-3668549-B1 APOMERS ABIONYX PHARMA SA (FR) 2024-05-15 EP claimed
US-11980395-B2 Methods and devices for sonographic imaging FEMASYS INC. (US) 2024-05-14 US claimed
EP-2405903-B1 COMPOSITIONS COMPRISING A FATTY ACID OIL MIXTURE AND A FREE FATTY ACID, AND METHODS AND USES THEREOF BASF AS (NO) 2024-04-10 EP claimed
EP-4347662-A1 ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF Myeloid Therapeutics, Inc. (US) 2024-04-10 EP claimed
EP-0094692-B1 COATED UBIDECARENONE-CONTAINING LIPOSOME Eisai Co., Ltd. (JP) 1986-08-27 EP claimed
EP-0099924-B1 IMMUNOLOGIC ASSAY FOR DETERMINING PRESENCE OF A PHOSPHOLIPID IN BIOLOGICAL FLUID HANA BIOLOGICS, INC. (US) 1986-05-07 EP claimed
EP-0068293-B1 A NEW NEMATOCIDAL COMPOSITION, PROCESSES FOR ITS PRODUCTION AND ITS USE A. Nattermann & Cie. GmbH (DE) 1985-08-28 EP claimed
EP-0068295-B1 A NEW HERBICIDAL COMPOSITION, PROCESSES FOR ITS PRODUCTION AND ITS USE A. Nattermann & Cie. GmbH (DE) 1985-08-28 EP claimed
EP-0099924-A4 IMMUNOLOGIC ASSAY FOR DETERMINING PRESENCE OF A PHOSPHOLIPID IN BIOLOGICAL FLUID. HANA BIOLOG INC (US) 1984-06-29 EP claimed
EP-0099924-A1 IMMUNOLOGIC ASSAY FOR DETERMINING PRESENCE OF A PHOSPHOLIPID IN BIOLOGICAL FLUID. HANA BIOLOG INC (US) 1984-02-08 EP claimed
EP-0090339-A2 Method and reagent for the enzymatical determination of phosphatidyl glycerol Roche Diagnostics GmbH (DE) 1983-10-05 EP claimed
WO-1983002672-A1 IMMUNOLOGIC ASSAY FOR DETERMINING PRESENCE OF A PHOSPHOLIPID IN BIOLOGICAL FLUID HANA BIOLOG INC (US) 1983-08-04 WO claimed
EP-0036155-A2 Polymerisable phospholipids, process for their preparation, polymeric phospholipids, process for their preparation as well as the use of the polymeric phospholipids Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1981-09-23 EP claimed
EP-0004223-B1 PROCESS FOR THE PREPARATION OF LIPIDIC CAPSULES CONTAINING A BIOLOGICALLY ACTIVE COMPOUND, PRODUCTS OBTAINED BY THIS PROCESS AS WELL AS THEIR UTILISATION PAPAHADJOPOULOS, Demetrios P. (US) 1981-09-09 EP claimed